SCHEMBL6797941

SCHEMBL6797941

[NH][P](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.43
CA4 P22748 1/20 0.43
CA5A P35218 1/20 0.43
ESR1 P03372 3/20 0.38
ESR2 Q92731 2/20 0.38
CFTR P13569 1/20 0.38
ALDH1A1 P00352 6/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALOX12 P18054 2/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 1/20 0.36
ALPG P10696 1/20 0.36
NPY1R P25929 1/20 0.36
HTT P42858 1/20 0.36
NPY2R P49146 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 3/20 0.35
ALOX15 P16050 2/20 0.35
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29008512 0.80 CA2 (0.39) CA2CA4CA5AESR1ESR2
SCHEMBL2932036 0.77 CA2 (0.47) CA2CA4CA5AESR1ESR2
SCHEMBL29183480 0.74 CA2 (0.45) CA2CA4CA5AESR1ESR2
SCHEMBL22470753 0.74 CA2 (0.45) CA2CA4CA5AESR1ESR2
Iodide SCHEMBL8529104 0.74 CA2 (0.45) CA2CA4CA5AESR1ESR2
Hydrochloric Acid SCHEMBL28961494 0.74 CA2 (0.45) CA2CA4CA5AESR1ESR2
SCHEMBL1382562 0.73 CA2 (0.52) CA2CA4CA5AESR1CFTR
SCHEMBL7660039 0.73 ESR1 (0.46) CA2CA4CA5AESR1ESR2
SCHEMBL361668 0.71 CA2 (0.43) CA2CA4CA5AESR1ESR2
SCHEMBL5155948 0.69 CA2 (0.62) CA2CA4CA5AESR1CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110665-A1 Desleucyl glycopeptide antibiotics and methods of making same KAHNE DANIEL (US) 2004-06-10 US disclosed
US-6518243-B1 Desleucyl glycopeptide antibiotics and methods of making same TRUSTEES OF PRINCETON UNIVERSITY 2003-02-11 US disclosed
EP-1173193-A4 DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME UNIV PRINCETON (US) 2003-01-29 EP disclosed
EP-1173193-A1 DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME The Trustees of Princeton University (US) 2002-01-23 EP disclosed
WO-2000059528-A1 DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2000-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110665-A1 Desleucyl glycopeptide antibiotics and methods of making same FUT6, FUT5, ST6GAL1 CA2 4043/4885CA4 1743/4885CA5A 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.